A Phase I/IIa Study of BMS 986148, a Mesothelin Directed Antibody Drug Conjugate, in Subjects with Select Advanced Solid Tumors

  • Day, Daphne (Primary Chief Investigator (PCI))
  • Markman, Ben (Chief Investigator (CI))
  • Body, Amy (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Monash Health HREC Ref: 15024A

StatusActive
Effective start/end date12/12/1811/12/23